Covid-19 vaccines, lockdowns and equities
Insights

Covid-19 vaccines, lockdowns and equities

With the Covid-19 case count rising rapidly across the United States and Europe, the immediate economic outlook associated with renewed lockdowns is turning darker. But announcements from Pfizer and Moderna around the efficacy of their vaccines has cheered financial markets considerably. So how do we approach the possible short-term deterioration in economic data with the greater certainty about the longer-term path to normalisation?

Better-than-expected vaccine results drive markets higher

Our expectation, and the expectation of many forecasters, had been for vaccine candidates to report decent rather than spectacular efficacies, and for vaccines to begin to be deployed towards the end of 2020. As such the recent news has been a positive surprise when compared to the base case. Furthermore, the tail-risk of no immediately successful vaccine has in the past week been summarily dismissed, and the associated implications for markets have been profound. Firms which were uninvestable without the prospect of a successful vaccine have become once more subject to analytical scrutiny. As such the significant advance and rotation in equity markets makes sense:
  • The firms most profoundly impacted by Covid-19, such as travel and leisure firms, have jumped enormously in value over recent days as they have become investable again
  • Firms that we would anticipate performing well under a reflationary environment have also risen impressively, although not to the same extent
  • Good-quality firms that will prosper under most scenarios (except one without a successful vaccine) have also performed well as the left-tail scenario has been cut.

Considering the longer-term impacts of Covid-19

However, the pandemic crisis has left a profound impact on the economy and on financial markets. Without the novel coronavirus we wouldn’t have had the deep and sudden weakening of the real economy that has given large public companies the opportunity to accelerate their disruption of “old economy” sectors. Time will tell the degree to which anti-trust or regulatory responses will slow or reverse this latest land grab.
Without the crisis we wouldn’t have seen long-dated bond yields plummet (and with them discount rates used to value risky assets), pushing up the present value of future cash flows. The degree of economic scarring is still unknown, but most analysts, investors and indeed policymakers are betting that there will be no rapid rise in long-dated yields given the disinflationary impact that Covid-19 has ushered-in, most likely for the next couple of years.
And without Covid we wouldn’t have had a spike higher in levels of household, corporate and government debt. Higher levels of debt do not necessarily imply higher levels of debt service, given the collapse in bond yields, but they do place some limits on the degree to which rates can rise before monetary tightening is effected – meaning that equilibrium interest rates are, all else being equal, likely to be lower.

Summary

It may seem paradoxical that equity markets are rallying into a new economic slowdown, but it is worth recalling that large public companies are only a subset of the economy and that equities are long-duration assets. As such, the most important news we have received over recent days is that one possible future – that of no successful vaccine – no longer looks likely. And that is something that financial markets and humans alike can find common ground in cheering.
27 November 2020
Share article
Share on linkedin
Share on email
Key topics
Related topics
Listen on Stitcher badge
Share article
Share on linkedin
Share on email
Key topics
Related topics

PDF

Covid-19 vaccines, lockdowns and equities

Important Information

With the Covid-19 case count rising rapidly across the United States and Europe, the immediate economic outlook associated with renewed lockdowns is turning darker. But announcements around efficacy on new vaccines has cheered financial markets considerably. So how do we approach the possible short-term deterioration in economic data with the greater certainty about the longer-term path to normalisation?

Related Insights

21 May 2024

Pauline Grange

Portfolio Manager, Global Equities

Water in crisis – searching for solutions

With too much, too little or too toxic water the world is facing a water crisis. We explore key issues and challenges before highlighting some of the companies promoting better water management.
Read time - 3 min
16 May 2024

Paul Doyle

Head of Europe ex-UK Equities

Positives for Europe, but the Middle East could be a headache

Inflation is a stubborn problem in the US due to labour shortages, but this is much less of a factor in Europe where activity is dull but likely to recover as the consumer is well supported.
Read time - 1 min
17 April 2024

In search of sustainability – following Highway 101

Travelling down the US west coast we met 25 companies in five days. Learn more about the tech and healthcare businesses shaping our future.
Read time - 3 min
21 June 2024

James Coke

Fund Manager & Co-head of Institutional UK Real Estate

Emma Gullifer

Assistant Fund Manager

Green to gold: realising opportunities from the carbon transition

We explore the interventions required to monetise green energy, and how investors might benefit from the carbon transition.
Read time - 2 min
20 June 2024

Gary Smith

Client Portfolio Manager, Fixed Income

What do geopolitical risks mean for central bank FX reserves managers?

Two major industry surveys show that adjusting for geopolitical challenges will impact the way foreign exchange reserves are managed
Read time - 8 min
19 June 2024

Sally Springer

Senior Thematic Research Analyst, Global Research

Human capital – supply: the impact of demographic transition on investments

Working populations are in decline, with the demographic dividend that has supported economic growth in many developed markets under threat. This will have a direct impact on the firms in which we invest.
Read time - 8 min
true
true

Important Information

With the Covid-19 case count rising rapidly across the United States and Europe, the immediate economic outlook associated with renewed lockdowns is turning darker. But announcements around efficacy on new vaccines has cheered financial markets considerably. So how do we approach the possible short-term deterioration in economic data with the greater certainty about the longer-term path to normalisation?

You may also like

Investment approach

Teamwork defines us and is fundamental to our investment approach, which is structured to facilitate the generation, assessment and implementation of good, strong investment ideas for our portfolios.

Funds and Prices

Columbia Threadneedle Investments has a comprehensive range of investment funds catering for a broad range of objectives.

Our Capabilities

We offer a broad range of actively managed investment strategies and solutions covering global, regional and domestic markets and asset classes.